167 related articles for article (PubMed ID: 37431661)
1. Malawi vaccination drive: An integrated immunization campaign against typhoid, measles, rubella, and polio; health benefits and potential challenges.
Lubanga AF; Bwanali AN; Munthali L; Mphepo M; Chumbi GD; Kangoma M; Khuluza C
Hum Vaccin Immunother; 2023 Aug; 19(2):2233397. PubMed ID: 37431661
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of co-administration of meningococcal type A and measles-rubella vaccines with typhoid conjugate vaccine in children aged 15-23 months in Burkina Faso.
Sirima SB; Ouedraogo A; Barry N; Siribie M; Tiono AB; Nébié I; Konaté AT; Berges GD; Diarra A; Ouedraogo M; Soulama I; Hema A; Datta S; Liang Y; Rotrosen ET; Tracy JK; Jamka LP; Neuzil KM; Laurens MB
Int J Infect Dis; 2021 Jan; 102():517-523. PubMed ID: 33176205
[TBL] [Abstract][Full Text] [Related]
3. A review of potential use cases for measles-rubella, measles-mumps-rubella, and typhoid-conjugate vaccines presented on microarray patches.
Soble A; Ko M; Gilchrist S; Malvolti S; Hasso-Agopsowicz M; Giersing B; Amorij JP; Jarrahian C; El Sheikh F; Menozzi-Arnaud M; Scarna T
Vaccine; 2024 Feb; 42(6):1230-1246. PubMed ID: 38326130
[TBL] [Abstract][Full Text] [Related]
4. Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study.
Hartner AM; Li X; Echeverria-Londono S; Roth J; Abbas K; Auzenbergs M; de Villiers MJ; Ferrari MJ; Fraser K; Fu H; Hallett T; Hinsley W; Jit M; Karachaliou A; Moore SM; Nayagam S; Papadopoulos T; Perkins TA; Portnoy A; Minh QT; Vynnycky E; Winter AK; Burrows H; Chen C; Clapham HE; Deshpande A; Hauryski S; Huber J; Jean K; Kim C; Kim JH; Koh J; Lopman BA; Pitzer VE; Tam Y; Lambach P; Sim SY; Woodruff K; Ferguson NM; Trotter CL; Gaythorpe KAM
Lancet Glob Health; 2024 Apr; 12(4):e563-e571. PubMed ID: 38485425
[TBL] [Abstract][Full Text] [Related]
5. Impact of an Intervention to Use a Measles, Rubella, and Polio Mass Vaccination Campaign to Strengthen Routine Immunization Services in Nepal.
Wallace AS; Bohara R; Stewart S; Subedi G; Anand A; Burnett E; Giri J; Shrestha J; Gurau S; Dixit S; Rajbhandari R; Schluter WW
J Infect Dis; 2017 Jul; 216(suppl_1):S280-S286. PubMed ID: 28838201
[TBL] [Abstract][Full Text] [Related]
6. Transitioning Lessons Learned and Assets of the Global Polio Eradication Initiative to Global and Regional Measles and Rubella Elimination.
Kretsinger K; Strebel P; Kezaala R; Goodson JL
J Infect Dis; 2017 Jul; 216(suppl_1):S308-S315. PubMed ID: 28838195
[TBL] [Abstract][Full Text] [Related]
7. Measles, mumps, rubella prevention: how can we do better?
Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
[TBL] [Abstract][Full Text] [Related]
8. Post-vaccination campaign coverage evaluation of oral cholera vaccine, oral polio vaccine and measles-rubella vaccine among Forcibly Displaced Myanmar Nationals in Bangladesh.
Khan AI; Islam MT; Siddique SA; Ahmed S; Sheikh N; Siddik AU; Islam MS; Qadri F
Hum Vaccin Immunother; 2019; 15(12):2882-2886. PubMed ID: 31441679
[No Abstract] [Full Text] [Related]
9. Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9-15 months old Nepalese infants.
Saluja T; Rai GK; Chaudhary S; Kanodia P; Giri BR; Kim DR; Yang JS; Park IY; Kyung SE; Vemula S; Reddy E J; Kim B; Gupta BP; Jo SK; Ryu JH; Park HK; Shin JH; Lee Y; Kim H; Kim JH; Mojares ZR; Wartel TA; Sahastrabuddhe S
Vaccine; 2022 Sep; 40(40):5828-5834. PubMed ID: 36064672
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
Uddin MJ; Adhikary G; Ali MW; Ahmed S; Shamsuzzaman M; Odell C; Hashiguchi L; Lim SS; Alam N
BMC Infect Dis; 2016 Aug; 16():411. PubMed ID: 27519586
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study.
Phillips MT; Antillon M; Bilcke J; Bar-Zeev N; Limani F; Debellut F; Pecenka C; Neuzil KM; Gordon MA; Thindwa D; Paltiel AD; Yaesoubi R; Pitzer VE
BMC Infect Dis; 2023 Mar; 23(1):143. PubMed ID: 36890448
[TBL] [Abstract][Full Text] [Related]
12. Expansion of Vaccination Services and Strengthening Vaccine-Preventable Diseases Surveillance in Haiti, 2010-2016.
Tohme RA; Francois J; Cavallaro KF; Paluku G; Yalcouye I; Jackson E; Wright T; Adrien P; Katz MA; Hyde TB; Faye P; Kimanuka F; Dietz V; Vertefeuille J; Lowrance D; Dahl B; Patel R
Am J Trop Med Hyg; 2017 Oct; 97(4_Suppl):28-36. PubMed ID: 29064356
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of inactivated poliovirus vaccine when given with measles-rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia.
Clarke E; Saidu Y; Adetifa JU; Adigweme I; Hydara MB; Bashorun AO; Moneke-Anyanwoke N; Umesi A; Roberts E; Cham PM; Okoye ME; Brown KE; Niedrig M; Chowdhury PR; Clemens R; Bandyopadhyay AS; Mueller J; Jeffries DJ; Kampmann B
Lancet Glob Health; 2016 Aug; 4(8):e534-47. PubMed ID: 27364568
[TBL] [Abstract][Full Text] [Related]
14. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
[TBL] [Abstract][Full Text] [Related]
15. Implications of COVID-19 and "super floods" for routine vaccination in Pakistan: The reemergence of vaccine preventable-diseases such as polio and measles.
Ali I; Hamid S
Hum Vaccin Immunother; 2022 Dec; 18(7):2154099. PubMed ID: 36573023
[TBL] [Abstract][Full Text] [Related]
16. Prospects for the eradication of infectious diseases.
Stuart-Harris C
Rev Infect Dis; 1984; 6(3):405-11. PubMed ID: 6377445
[TBL] [Abstract][Full Text] [Related]
17. Estimated number of reported vaccine-preventable disease cases averted following the introduction of routine vaccination programs in Sweden, 1910-2019.
Martin LJ; Galanis I; Lepp T; Lindstrand A
Eur J Public Health; 2023 Dec; 33(6):1188-1193. PubMed ID: 37883058
[TBL] [Abstract][Full Text] [Related]
18. Measles-rubella mass immunization campaign in Albania, November 2000.
Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Strategies and Incidence Thresholds for Vi Conjugate Vaccines Against Typhoid Fever: A Cost-effectiveness Modeling Study.
Lo NC; Gupta R; Stanaway JD; Garrett DO; Bogoch II; Luby SP; Andrews JR
J Infect Dis; 2018 Nov; 218(suppl_4):S232-S242. PubMed ID: 29444257
[TBL] [Abstract][Full Text] [Related]
20. Timeliness and completeness of routine childhood vaccinations in young children residing in a district with recurrent vaccine-preventable disease outbreaks, Jerusalem, Israel.
Stein-Zamir C; Israeli A
Euro Surveill; 2019 Feb; 24(6):. PubMed ID: 30755293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
